![Renato T. Skerlj](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Renato T. Skerlj
Chief Executive Officer at Expansion Therapeutics, Inc.
Renato T. Skerlj active positions
Companies | Position | Start | End |
---|---|---|---|
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Director/Board Member | 05/10/2020 | - |
Chief Executive Officer | 05/10/2020 | - | |
President | 05/10/2020 | - |
Career history of Renato T. Skerlj
Former positions of Renato T. Skerlj
Companies | Position | Start | End |
---|---|---|---|
AnorMED, Inc.
![]() AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Corporate Officer/Principal | 01/05/1998 | 09/11/2006 |
X4 PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/09/2019 | - |
X4 PHARMACEUTICALS, INC. | Founder | 01/01/2010 | - |
X4 Pharmaceuticals, Inc. /Old/
![]() X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Founder | 01/07/2014 | - |
Lysosomal Therapeutics, Inc.
![]() Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Training of Renato T. Skerlj
University of British Columbia | Doctorate Degree |
Statistics
International
United States | 5 |
Canada | 3 |
Operational
Corporate Officer/Principal | 2 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
X4 PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
AnorMED, Inc.
![]() AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
Lysosomal Therapeutics, Inc.
![]() Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
![]() X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Health Technology |
- Stock Market
- Insiders
- Renato T. Skerlj
- Experience